A medium sized pharmaceutical firm conducted a 56 week phase III trial to access the safety and efficiency of an obesity treatment program.
Goal: Retrieve patient contact information from each site, locate the current contact information and return it to the site. If a patient was deceased we were to provide their date of death and the resource of such data. Additionally, we were to attempt to obtain a death certificate for each subject. If the subject was alive, we were to provide the most recent “alive as of” date.
Total Subjects: 416
Number of sites: 87
Result: OmniTrace successfully determined the vital status for 99% of the subjects provided.